P50CA98131/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2006	2
2009	1
2010	3
2011	9
2012	7
2013	4
2014	2
2015	2
2024	0

1

Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer.

Miller TW, Balko JM, Arteaga CL. Miller TW, et al. J Clin Oncol. 2011 Nov 20;29(33):4452-61. doi: 10.1200/JCO.2010.34.4879. Epub 2011 Oct 17. J Clin Oncol. 2011. PMID: 22010023 Free PMC article. Review.

2

Cardiac side effects of anticancer treatments: new mechanistic insights.

Geisberg C, Pentassuglia L, Sawyer DB. Geisberg C, et al. Curr Heart Fail Rep. 2012 Sep;9(3):211-8. doi: 10.1007/s11897-012-0098-4. Curr Heart Fail Rep. 2012. PMID: 22752360 Free PMC article. Review.

3

Phosphatase and tensin homolog deficiency and resistance to trastuzumab and chemotherapy.

Rexer BN, Shyr Y, Arteaga CL. Rexer BN, et al. J Clin Oncol. 2013 Jun 10;31(17):2073-5. doi: 10.1200/JCO.2012.48.5243. Epub 2013 May 6. J Clin Oncol. 2013. PMID: 23650407 No abstract available.

4

Initiating breast cancer by PIK3CA mutation.

Miller TW. Miller TW. Breast Cancer Res. 2012 Feb 7;14(1):301. doi: 10.1186/bcr3103. Breast Cancer Res. 2012. PMID: 22315990 Free PMC article.

5

Clinical development of phosphatidylinositol-3 kinase pathway inhibitors.

Arteaga CL. Arteaga CL. Curr Top Microbiol Immunol. 2010;347:189-208. doi: 10.1007/82_2010_54. Curr Top Microbiol Immunol. 2010. PMID: 20593313 Free PMC article. Review.

6

Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer.

Miller TW, Rexer BN, Garrett JT, Arteaga CL. Miller TW, et al. Breast Cancer Res. 2011;13(6):224. doi: 10.1186/bcr3039. Epub 2011 Nov 1. Breast Cancer Res. 2011. PMID: 22114931 Free PMC article. Review.

7

Nuclear p63 expression in osteoblastic tumors.

Kallen ME, Sanders ME, Gonzalez AL, Black JO, Keedy VL, Hande KR, Homlar KC, Halpern JL, Holt GE, Schwartz HS, Coffin CM, Cates JM. Kallen ME, et al. Tumour Biol. 2012 Oct;33(5):1639-44. doi: 10.1007/s13277-012-0419-y. Epub 2012 May 25. Tumour Biol. 2012. PMID: 22623071

8

Optimal targeting of HER2-PI3K signaling in breast cancer: mechanistic insights and clinical implications.

Rexer BN, Arteaga CL. Rexer BN, et al. Cancer Res. 2013 Jul 1;73(13):3817-20. doi: 10.1158/0008-5472.CAN-13-0687. Epub 2013 Jun 21. Cancer Res. 2013. PMID: 23794708 Free PMC article. Review.

9

SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity.

Kim HS, Vassilopoulos A, Wang RH, Lahusen T, Xiao Z, Xu X, Li C, Veenstra TD, Li B, Yu H, Ji J, Wang XW, Park SH, Cha YI, Gius D, Deng CX. Kim HS, et al. Cancer Cell. 2011 Oct 18;20(4):487-99. doi: 10.1016/j.ccr.2011.09.004. Cancer Cell. 2011. PMID: 22014574 Free PMC article.

10

Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer.

Dennison JB, Molina JR, Mitra S, González-Angulo AM, Balko JM, Kuba MG, Sanders ME, Pinto JA, Gómez HL, Arteaga CL, Brown RE, Mills GB. Dennison JB, et al. Clin Cancer Res. 2013 Jul 1;19(13):3703-13. doi: 10.1158/1078-0432.CCR-13-0623. Epub 2013 May 22. Clin Cancer Res. 2013. PMID: 23697991 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year